Navigation Links
Par Pharmaceutical Companies Reports Second Quarter 2011 Results
Date:8/3/2011

ons (non-GAAP measure)$0.84$0.71Diluted weighted average shares outstanding

36,70835,475Six Months EndedJune 30,June 30,20112010(Loss) Income from Continuing Operations($99,664)$44,461Litigation settlements and contingencies, pre-tax

190,560(4,130)Restructuring costs

27,660-Upfront and development milestone payments

-17,000Sale of product rights

-(5,000)Non-cash interest expense

-1,038Sum of adjustments, pre-tax

$218,220$8,908Estimated tax on adjustments

(58,909)(3,385)Charge related to valuation of deferred income tax assets

2,391-Resolution of tax contingencies

-(3,657)Adjusted Income from Continuing Operations (non-GAAP measure)

$62,038$46,327Amortization Expense

6,1188,154Estimated tax impact

(2,295)(3,099)Amortization Expense, net of tax

3,8235,055Adjusted Cash basis from Continuing Operations (non-GAAP measure)65,86151,382"Cash EPS" from Continuing Operations (non-GAAP measure)$1.80$1.46Diluted weighted average shares outstanding

36,55535,273
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
2. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
3. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
4. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
5. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
6. Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Companys New U.S. Headquarters
7. FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
9. BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production
10. Though Essential to Pharmaceutical Sales Success, the Use of Health Outcomes Data Often Overlooked by Sales Leaders
11. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... approval of Zarxio (filgrastim-sndz) -- the first biosimilar ... -- points toward growth in the ... Information. The mainstream CMO industry is geared to ... infrastructure to produce major biopharmaceutical products. The healthcare ...
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... 2015   InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" ... ("EPS"), today announced that its CGuard TM Embolic Prevention ... Prof. Piotr Musialek , at the EuroPCR ... . PARADIGM, an investigator-initiated P rospective ... roti D revascularization I n symptomatic and increased-risk ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
(Date:5/24/2015)... A report out just last month ... option for avoiding cardiovascular disease is exercise and maintaining ... single most powerful predictor of death and survival, even ... family history of premature death -- a finding that ... fitness. , The Importance of Cardiovascular Screening , The ...
(Date:5/23/2015)... Dr. David Benvenuti, an experienced plastic surgeon who practices ... article to his website that takes an in-depth look ... in the fascinating blog, he has recently had several young ... as “gauging,” the technique involves placing larger and larger gauge ... eventually stretch the holes out to incredible sizes. As the ...
(Date:5/23/2015)... On May 16, the team at Farrell’s ... 5k mud obstacle run that raised funds for multiple sclerosis. ... and the reason we participated was to support people living ... Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised go ... was not only attended by eXtreme Bodyshaping staff, but members ...
(Date:5/23/2015)... May 23, 2015 Javon Bea ... the Sports Medicine and Rehabilitation Center, 557 N. Washington ... Mondays, June 1-July 20, 5:30-6:30 pm. , The 8-week ... and Laurie Finke, RN, BSN, who will offer training ... on nutrition, running mechanics and show selection and weekly ...
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
Breaking Medicine News(10 mins):Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3
... BioForm Medical,Inc. (Nasdaq: BFRM ) announced that ... 30, 2007 first quarter fiscal year 2008 financial,results. The ... NASDAQ,Global Market closes and will hold a conference call ... Time)., BioForm Chief Executive Officer Steve Basta and ...
... Activists Awarded Three-Year $5.2,Million Grant, SAN FRANCISCO, ... of the International Treatment Preparedness Coalition,and Tides, announced ... for $5.2,million from the Bill & Melinda Gates ... in advocacy and educational,activities to increase access to ...
... National partners,from the 16th annual Halloween Promotion benefiting ... million of the projected $4.8,million donation to the ... cancer. Companies represented at the check presentation included,A&P ... Store, Fox,& Hound, Hess Corporation, Petro Stopping Centers, ...
... to Kids Across the U.S.,on World Allergy Day, ... largest,allergy patient advocacy organization in the world, the ... holidays a little brighter for,children coast-to-coast who are ... by donating over 1,000 certified asthma &,allergy friendly(TM) ...
... themselves can raise their aspirations, motivation and accomplishments,and are ... do them., So says Albert Bandura, a Stanford ... the 2008 University of Louisville,Grawemeyer Award for Psychology. He ... 31 nominations from five countries., Bandura,s ideas have ...
... Dec. 4 Mylan Inc. (NYSE: MYL ... tentative,approval from the U.S. Food and Drug Administration ... (PEPFAR) for its Abbreviated New,Drug Application (ANDA) for ... Fumarate is the first and only generic,tentative approval ...
Cached Medicine News:Health News:BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 3Health News:National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer 2Health News:Allergy Foundation Thinks Globally, Gifts Locally 2Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2Health News:Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets 2
... the results and outcomes of ocular ... clues to diagnosing and managing ocular ... properties of corneal tissue has not ... to measuring purely geometrical aspects of ...
Diamond Reusable Probed work with all ACMI™ instrument inserts. Dual trumpet valves provide smooth, effective fingertip control over suction and irrigation....
... Tear Pool punctum plugs. Tear Pool punctum plugs ... with no additives via a precision molding process. ... which is designed to facilitate insertion as well ... position in the punctum. The cap of the ...
... performance ultrasound design provides unique advantages ... imaging requires superior spatial resolution, high ... The Terason Echo Ultrasound System, based ... a compact imaging platform without sacrificing ...
Medicine Products: